Warning: This security is no longer trading.
defunct
Conatus Pharmaceuticals Inc. (CNAT): Price and Financial Metrics
CNAT Price/Volume Stats
| Current price | $0.56 | 52-week high | $1.07 |
| Prev. close | $0.56 | 52-week low | $0.23 |
| Day low | $0.54 | Volume | 1,696,900 |
| Day high | $0.59 | Avg. volume | 1,283,592 |
| 50-day MA | $0.38 | Dividend yield | N/A |
| 200-day MA | $0.37 | Market Cap | 18.44M |
CNAT Stock Price Chart Interactive Chart >
Conatus Pharmaceuticals Inc. (CNAT) Company Bio
Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. The company was founded in 2005 and is based in San Diego, California.
CNAT Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 62.98% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | -76.88% |
Continue Researching CNAT
Want to do more research on Conatus Pharmaceuticals Inc's stock and its price? Try the links below:Conatus Pharmaceuticals Inc (CNAT) Stock Price | Nasdaq
Conatus Pharmaceuticals Inc (CNAT) Stock Quote, History and News - Yahoo Finance
Conatus Pharmaceuticals Inc (CNAT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...